|
ZNF92 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00399999999989E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.233300E-04 |
| Normal-vs-Stage2 |
2.192200E-02 |
| Normal-vs-Stage3 |
1.461970E-01 |
| Normal-vs-Stage4 |
4.248000E-01 |
| Stage1-vs-Stage2 |
2.801600E-01 |
| Stage1-vs-Stage3 |
3.007000E-01 |
| Stage1-vs-Stage4 |
1.599420E-01 |
| Stage2-vs-Stage3 |
1.499410E-01 |
| Stage2-vs-Stage4 |
9.095600E-02 |
| Stage3-vs-Stage4 |
6.799000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.016270E-04 |
| Normal-vs-AfricanAmerican |
6.243500E-03 |
| Normal-vs-Asian |
1.881830E-01 |
| Caucasian-vs-AfricanAmerican |
9.970200E-01 |
| Caucasian-vs-Asian |
7.166000E-01 |
| AfricanAmerican-vs-Asian |
7.247000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.965870E-04 |
| Normal-vs-Female |
1.843130E-04 |
| Male-vs-Female |
1.685780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.143900E-02 |
| Normal-vs-Extreme_Weight |
6.736500E-03 |
| Normal-vs-Obese |
1.061300E-03 |
| Normal-vs-Extreme_Obese |
2.962400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.752000E-01 |
| Normal_Weight-vs-Obese |
3.724200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.409800E-01 |
| Extreme_Weight-vs-Obese |
7.896800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.089200E-01 |
| Obese-vs-Extreme_Obese |
6.431200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.965630E-02 |
| Normal-vs-Age(41-60Yrs) |
1.2243000000467E-06 |
| Normal-vs-Age(61-80Yrs) |
6.624500E-03 |
| Normal-vs-Age(81-100Yrs) |
5.308800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.197770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.835800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.381400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.975600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.694180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.630200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.96960000034652E-07 |
| Normal-VS-Type2 PRCC |
6.390000E-01 |
| Normal-VS-KIRP CIMP |
5.133200E-01 |
| Normal-VS-Unclassified PRCC |
1.147810E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.162870E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.298430E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.790600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.428200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.824200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.136230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.322800E-01 |
| Normal-vs-N1 |
1.170020E-02 |
| Normal-vs-N2 |
1.987200E-01 |
| N0-vs-N1 |
2.795700E-02 |
| N0-vs-N2 |
2.376600E-01 |
| N1-vs-N2 |
7.145900E-02 |
|
|
